Summary: Tandem Diabetes Care (TNDM) had its outlook upgraded from Equal-Weight to Overweight by Wells Fargo. The average price target suggests a 1.09% downside. Funds reporting positions in TNDM increased by 35, and there is a bullish outlook indicated by a put/call ratio of 0.55.
Full articleSummary: Multiple companies have had their stock target prices adjusted by various analysts, including Jefferies, Bernstein, and Raymond James.
Full article